Lietuviški medsukiai - Company finances
|
EUR
|
2022
From: 2022-01-24
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-20
To: 2026-01-19
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 118,797 | 78,452 | 79,556 | 76,613 |
| Profit before tax | 61,987 | 33,896 | 24,745 | 10,945 |
| Net profit | 59,006 | 32,276 | 23,561 | 10,271 |
| Equity | 59,006 | 70,797 | 34,184 | 25,273 |
| Liabilities | 5,052 | 43,688 | 25,149 | 15,731 |
| Non-current assets | 0 | 50,417 | 39,011 | 27,890 |
| Current assets | 64,058 | 64,068 | 20,322 | 13,114 |
| Total assets | 64,058 | 114,485 | 59,333 | 41,004 |
|
Taxes paid
|
||||
| STI taxes | - | 13,113 | - | 9,155 |
|
Financial indicators
|
||||
| Revenue change y/y | - | -34.0% | +1.4% | -3.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 92.1% | 28.2% | 39.7% | 25.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 45.6% | 68.9% | 40.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 49.7% | 41.1% | 29.6% | 13.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 52.2% | 43.2% | 31.1% | 14.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.6 | 0.7 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 76,613 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Lietuviški medsukiai - Social security debts
The amount of overdue SODRA debt for the company Lietuviški medsukiai as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-13 | 0.24 |
| 2026-08-26 | 2026-09-02 | 0.24 |
| 2026-08-23 | 2026-08-23 | 0.24 |
| 2026-08-19 | 2026-08-19 | 0.24 |
| 2026-08-16 | 2026-08-17 | 0.24 |
| 2026-07-27 | 2026-08-14 | 0.24 |
| 2026-07-26 | 2026-07-26 | 0.19 |
| 2026-07-23 | 2026-07-25 | 0.24 |
| 2026-07-16 | 2026-07-22 | 0.19 |
| 2026-05-22 | 2026-06-04 | 0.20 |
| 2026-05-17 | 2026-05-21 | 24.23 |
| 2026-05-03 | 2026-05-14 | 0.20 |
| 2026-04-24 | 2026-04-29 | 0.20 |
| 2026-02-18 | 2026-02-25 | 24.02 |
| 2026-01-21 | 2026-02-08 | 24.02 |
| 2026-01-16 | 2026-01-20 | 23.98 |
| 2025-12-16 | 2025-12-28 | 5.29 |
| 2025-11-18 | 2025-12-15 | 2.62 |
| 2025-03-01 | 2025-03-31 | 72.40 |
| 2022-03-01 | 2022-03-31 | 50.95 |
Lietuviški medsukiai - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Lietuviški medsukiai is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 0.32 |
| 2026-07-31 | 2026-08-25 | 0.32 |
| 2025-10-02 | 2025-10-24 | 0.12 |
| 2025-09-30 | 2025-10-01 | 1470.22 |
| 2024-12-30 | 2024-12-30 | 151.11 |
| 2024-10-28 | 2024-12-29 | 0.11 |
| 2024-09-29 | 2024-10-16 | 0.11 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lietuviški medsukiai, MB (company code 305990744) is a Small partnership engaged in the manufacture of other metal tanks, reservoirs and containers. In the latest financial year 2025, the company generated revenue of €76.6K and net profit of €10.3K, with a profit margin of 13.4%. Revenue declined by 3.7% year on year and was 2.3% lower than two years earlier, indicating a relatively stable but slightly weakening sales base. Profitability has decreased more noticeably over the period: net profit fell from €32.3K in 2023 to €23.6K in 2024 and then to €10.3K in 2025. The balance sheet also contracted, with total assets down to €41.0K in 2025 from €59.3K in 2024 and €114.5K in 2023. Equity stood at €25.3K and liabilities at €15.7K, giving an equity ratio of 61.6% and debt-to-equity of 0.62. Asset turnover reached 1.87x, while return on equity was 40.6% and return on assets 25.1%. Revenue per employee was €76.6K and profit per employee €10.3K.